BEONE MEDICINES Interim Net Profit Up 385.8% to USD464M; ADR Gains 0.7% Premarket
CSPC Pharma says FDA grants Fast Track status to SYS6090 for MSS/pMMR metastatic colorectal cancer
HANSOH PHARMA 1H26 Net Profit Up 35.8% YoY to RMB4.258B; Interim DPS Hiked 23% to HKD0.285
Hansoh Pharma FY26 H1 profit rises 35.8% to RMB 4.26 billion; revenue increases 11.7% to RMB 8.3 billion
Hong Kong stock movement: Performance exceeds expectations + Goldman Sachs upgrades rating, INNOVENT BIO rises 10.09%
INNOVENT BIO Surges Over 8% as Results Beat Expectations; G Sachs and CLSA Raise TP